172 related articles for article (PubMed ID: 37679505)
1. MC1R signaling through the cAMP-CREB/ATF-1 and ERK-NFκB pathways accelerates G1/S transition promoting breast cancer progression.
Chelakkot VS; Thomas K; Romigh T; Fong A; Li L; Ronen S; Chen S; Funchain P; Ni Y; Arbesman J
NPJ Precis Oncol; 2023 Sep; 7(1):85. PubMed ID: 37679505
[TBL] [Abstract][Full Text] [Related]
2. Palmitoylation-dependent activation of MC1R prevents melanomagenesis.
Chen S; Zhu B; Yin C; Liu W; Han C; Chen B; Liu T; Li X; Chen X; Li C; Hu L; Zhou J; Xu ZX; Gao X; Wu X; Goding CR; Cui R
Nature; 2017 Sep; 549(7672):399-403. PubMed ID: 28869973
[TBL] [Abstract][Full Text] [Related]
3. Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT.
Herraiz C; Journé F; Abdel-Malek Z; Ghanem G; Jiménez-Cervantes C; García-Borrón JC
Mol Endocrinol; 2011 Jan; 25(1):138-56. PubMed ID: 21084381
[TBL] [Abstract][Full Text] [Related]
4. Functional status and relationships of melanocortin 1 receptor signaling to the cAMP and extracellular signal-regulated protein kinases 1 and 2 pathways in human melanoma cells.
Herraiz C; Journé F; Ghanem G; Jiménez-Cervantes C; García-Borrón JC
Int J Biochem Cell Biol; 2012 Dec; 44(12):2244-52. PubMed ID: 23000456
[TBL] [Abstract][Full Text] [Related]
5. Melanin content and MC1R function independently affect UVR-induced DNA damage in cultured human melanocytes.
Hauser JE; Kadekaro AL; Kavanagh RJ; Wakamatsu K; Terzieva S; Schwemberger S; Babcock G; Rao MB; Ito S; Abdel-Malek ZA
Pigment Cell Res; 2006 Aug; 19(4):303-14. PubMed ID: 16827749
[TBL] [Abstract][Full Text] [Related]
6. cAMP-independent non-pigmentary actions of variant melanocortin 1 receptor: AKT-mediated activation of protective responses to oxidative DNA damage.
Castejón-Griñán M; Herraiz C; Olivares C; Jiménez-Cervantes C; García-Borrón JC
Oncogene; 2018 Jul; 37(27):3631-3646. PubMed ID: 29622793
[TBL] [Abstract][Full Text] [Related]
7. MC1R and the response of melanocytes to ultraviolet radiation.
Rouzaud F; Kadekaro AL; Abdel-Malek ZA; Hearing VJ
Mutat Res; 2005 Apr; 571(1-2):133-52. PubMed ID: 15748644
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous pharmacologic cAMP induction induces melanization of the skin and improves recovery from ultraviolet injury in melanocortin 1 receptor-intact or heterozygous skin.
Bautista RM; Carter KM; Jarrett SG; Napier D; Wakamatsu K; Ito S; D'Orazio JA
Pigment Cell Melanoma Res; 2020 Jan; 33(1):30-40. PubMed ID: 31398282
[TBL] [Abstract][Full Text] [Related]
9. Variants of the melanocortin-1 receptor: do they matter clinically?
Haddadeen C; Lai C; Cho SY; Healy E
Exp Dermatol; 2015 Jan; 24(1):5-9. PubMed ID: 25219681
[TBL] [Abstract][Full Text] [Related]
10. MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation.
García-Borrón JC; Abdel-Malek Z; Jiménez-Cervantes C
Pigment Cell Melanoma Res; 2014 Sep; 27(5):699-720. PubMed ID: 24807163
[TBL] [Abstract][Full Text] [Related]
11. Loss-of-function variants of the human melanocortin-1 receptor gene in melanoma cells define structural determinants of receptor function.
Sánchez Más J; Olivares Sánchez C; Ghanem G; Haycock J; Lozano Teruel JA; García-Borrón JC; Jiménez-Cervantes C
Eur J Biochem; 2002 Dec; 269(24):6133-41. PubMed ID: 12473109
[TBL] [Abstract][Full Text] [Related]
12. Significance of the Melanocortin 1 and Endothelin B Receptors in Melanocyte Homeostasis and Prevention of Sun-Induced Genotoxicity.
Swope VB; Abdel-Malek ZA
Front Genet; 2016; 7():146. PubMed ID: 27582758
[TBL] [Abstract][Full Text] [Related]
13. Melanocortins and the melanocortin 1 receptor, moving translationally towards melanoma prevention.
Abdel-Malek ZA; Swope VB; Starner RJ; Koikov L; Cassidy P; Leachman S
Arch Biochem Biophys; 2014 Dec; 563():4-12. PubMed ID: 25017567
[TBL] [Abstract][Full Text] [Related]
14. Targeting MC1R depalmitoylation to prevent melanomagenesis in redheads.
Chen S; Han C; Miao X; Li X; Yin C; Zou J; Liu M; Li S; Stawski L; Zhu B; Shi Q; Xu ZX; Li C; Goding CR; Zhou J; Cui R
Nat Commun; 2019 Feb; 10(1):877. PubMed ID: 30787281
[TBL] [Abstract][Full Text] [Related]
15. Differential and competitive regulation of human melanocortin 1 receptor signaling by β-arrestin isoforms.
Abrisqueta M; Herraiz C; Pérez Oliva AB; Sanchez-Laorden BL; Olivares C; Jiménez-Cervantes C; García-Borrón JC
J Cell Sci; 2013 Aug; 126(Pt 16):3724-37. PubMed ID: 23750009
[TBL] [Abstract][Full Text] [Related]
16. Rate limiting factors in melanocortin 1 receptor signalling through the cAMP pathway.
Más JS; Gerritsen I; Hahmann C; Jiménez-Cervantes C; García-Borrón JC
Pigment Cell Res; 2003 Oct; 16(5):540-7. PubMed ID: 12950734
[TBL] [Abstract][Full Text] [Related]
17. Melanocortin 1 receptor mutations impact differentially on signalling to the cAMP and the ERK mitogen-activated protein kinase pathways.
Herraiz C; Jiménez-Cervantes C; Zanna P; García-Borrón JC
FEBS Lett; 2009 Oct; 583(19):3269-74. PubMed ID: 19755124
[TBL] [Abstract][Full Text] [Related]
18. Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation.
Scott MC; Wakamatsu K; Ito S; Kadekaro AL; Kobayashi N; Groden J; Kavanagh R; Takakuwa T; Virador V; Hearing VJ; Abdel-Malek ZA
J Cell Sci; 2002 Jun; 115(Pt 11):2349-55. PubMed ID: 12006619
[TBL] [Abstract][Full Text] [Related]
19. Platelet-activating factor mediates MMP-2 expression and activation via phosphorylation of cAMP-response element-binding protein and contributes to melanoma metastasis.
Melnikova VO; Mourad-Zeidan AA; Lev DC; Bar-Eli M
J Biol Chem; 2006 Feb; 281(5):2911-22. PubMed ID: 16306050
[TBL] [Abstract][Full Text] [Related]
20. MC1R signaling. Intracellular partners and pathophysiological implications.
Herraiz C; Garcia-Borron JC; Jiménez-Cervantes C; Olivares C
Biochim Biophys Acta Mol Basis Dis; 2017 Oct; 1863(10 Pt A):2448-2461. PubMed ID: 28259754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
